For the Merck PD1, and for patients who are IPI refractory (didn’t respond to IPI/Yervoy)
Argawala St. Lukes, Easton, PA 484-503-4500 agarwas@slhn.org
Mayo Clinic Scottsdale, AZ
Adil Daud San Francisco, CA 415-533-8742 adaud@medicine.ucsf.edu
Hospital U. of PA: Lynn Schucter 800-789-PENN
Jorge Nieva Billings, MT 406-435-7415 jnieva@billingsclinic.org
Omid Hamid Angeles Clinic LA 310-294-0438 ohamid@theangelesclinic.org
Stephen Hodi Dana Farber, Boston,MA 617-632-5053 Stephen_Hodi@dfci.harvard.edu
Antoni Ribas, UCLA 310-206-3928
Hassane Zarour, Pittsburgh, pA 412-623-3272 zarourhm@upmc.edu
Luis Camacho Houston 832-355-3205 lcamacho@sleh.com
Steven Oday, Beverly Hills, Ca 310-432-8900 soday@bhcancercenter.com
Donald Lawrence Boston MA 617-643-3614 dplawrence@partners.org (UMASS)